IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-05-09 (tissuepathology.com)
Proscia Wins 2025 MedTech Breakthrough Award | .com
Proscia: Honored alongside Abbott, Johnson & Johnson, IQVIA, and ŌURA PHILADELPHIA —May 8, 2025—Proscia®, a software company leading pathology's transition to digital and AI, has been named a winner in the 2025 MedTech Breakthrough Awards program celebrating the world's most outstanding companies, products, and people in medical technology. Its Concentriq® AP-Dx* software platform was recognized for innovation, performance,
Read more
2025-03-10 (businesswire.com)
IQVIA recognized as a leader in IDC MarketScape's 2024 assessment for decentralized clinical trial technologies and consulting services
IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sciences ...
Read more
2025-02-24 (stocktitan.net)
IQVIA's Healthcare AI Assistant Wins Major Industry Innovation Award | IQV Stock News
Healthcare-grade AI technology recognized for revolutionizing life sciences analytics with secure, compliant, and precise decision-making capabilities
Read more
2025-02-05 (pharmiweb.com)
IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year -
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2025 Fortune® World’s Most Admired Companies™ list. This is the fourth year in a row IQVIA has earned first place in the Health Care: Pharmacy and Other ...
Read more
2025-02-04 (businesswire.com)
IQVIA named to the Fortune ® World's Most Admired Companies ™ list, ranked No. 1 in its sector for fourth consecutive year
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category o...
Read more
2024-12-18 (bosa.co.kr)
Dongwha Pharmaceutical's Pancol-S, No. 1 in cold medicine market sales for two consecutive years < Pharmaceutical industry < Pharmaceuticals/distribution < Text of article -
[Medical Newspaper/Daily Newspaper = Reporter Kim Jeong-il] Dongwha Pharmaceutical (CEO Yoo Jun-ha) announced on the 17th that its comprehensive cold medicine 'Pancol S' has ranked first in cold medicine market sales for two consecutive years. Recently announced 2024 IQVIA 3Q MAT data According to (2023 4Q ~ 2024 3Q), Dongwha Pharmaceutical Pancol S recorded sales of 35.8 billion won. Maintained first place. This amounts to about a 25% share of the cold medicine market worth about 143 billion won. Panchol S achieved first place in cold medicine sales for the first time in 2023 IQVIA 3Q MAT data (2022 4Q~2023 3Q). Dongwha Pharmaceutical
Read more
2024-12-18 (newscj.com)
Dongwha Pharm's Pancol-S achieves first place in cold medicine market sales for two consecutive years < Company/Industry < Economy < Text of article -
[Cheonji Ilbo = Reporter Hong Bo-young] Dongwha Pharmaceutical announced on the 17th that its comprehensive cold medicine 'Pancol-S' has ranked first in sales in the cold medicine market for two consecutive years. Recently announced 2024 IQVIA data from the 4th quarter of 2023 to 2024 In the third quarter, Pancol S sales recorded 35.8 billion won, maintaining its top spot in sales. This is about 14
Read more
2024-10-31 (vozlibre.com)
The FJD wins the Top 20 Award in “Global Hospital Management” and in four other healthcare areas for the seventh consecutive time
The Madrid center stood out among the more than 200 participants, also being recognized in the areas of “Digestive”, “Musculoskeletal”, “Kidney and Urinary Tracts” and “Respiratory”.
Read more
2024-10-24 (prnoticias.com)
The General University Hospital of Villalba, recognized with the Top 20 Award
The General University Hospital of Villalba, integrated into the Madrid public network (Sermas), yesterday added new recognition to its
Read more
2024-10-24 (isanidad.com)
Quirónsalud obtains 16 recognitions in the Iqvia Hospitales Top 20 Awards of 2024
Quirónsalud obtains 16 awards in the Iqvia Hospitales Top 20 Awards of 2024, recognizing its excellence in different clinical areas
Read more
2024-10-24 (monterrassa.cat)
MútuaTerrassa wins four IQVIA TOP20 Awards
The HUMT was distinguished for its Global Hospital Management, and in the areas of Digestive System, Pediatrics, Musculoskeletal
Read more
2024-10-23 (actualidad21.net)
The Getafe Public Hospital obtains four TOP 20 awards for the results of its management
The University Hospital of Getafe, belonging to the public health network of the Community of Madrid, has been awarded in the twenty-fifth edition of the TOP 20 Program in the areas of Global Hospital Management, Kidney and Urinary Tracts, Pediatrics and Costs, in recognition of your excellent
Read more
Used by 100+ compliance teams and analysts